Introduction 1
The epicardium plays a major role in the formation of embryonic heart. This outer mesothelial 2 layer of the heart contains multipotent progenitors, giving rise to smooth muscle cells of 3 coronary vessels as well as to cardiac fibroblasts that provide a stroma that drives formation 4 and alignment of myocardial fibers 1 . The epicardium is quiescent in healthy adult heart, but can 5 be reactivated following massive and acute injury. It thickens, expresses fetal genes, and 6 triggers differentiation of epicardial progenitors that can migrate into subjacent myocardium. 7
Hence, it has been shown that the epicardium can be a source of fibroblasts contributing to 8 fibrosis of the adult ventricular myocardium in response to acute ischemia 2 . In addition, we and 9
Yamaguchi et al have reported that atrial epicardial cells undergo epithelial-to-mesenchymal 10 transition (EMT), delaminate from the epicardium and differentiate into adipocytes contributing 11 to the accumulation of epicardial adipose tissue (EAT) both at the external face of the 12 epicardium and in the sub-epicardium 3, 4 . 13
In the atria, EAT is a common component of atrial histology. It is a source of free fatty 14 acid and of adipokines that can regulate the metabolism of the redox state of neighboring 15 myocardium 5,6 . However, both expansion and fibrotic remodeling of EAT are associated with 16 an increased risk of atrial fibrillation (AF), the most frequent cardiac arrhythmia in clinical 17 practice 7 . One mechanism linking fibro-fatty infiltration of the subepicardium and AF is that 18 this remodeling process contributes to the electrical dissociation between subepicardium and 19 subendocardium areas favoring focal fibrillation waves as recorded in patients with 20 longstanding AF 8, 9 . Hence, fibro fatty infiltration of the subepicardium is considered as an 21 important determinant of AF substrate. However, the underlying biological mechanisms are 22 still largely unknown. 23
The natriuretic peptide secreted by stretched atrial myocytes is a potent adipogenic 24 factor for adult epicardium progenitor-derived cells (aEPDCs) which might favor EAT expansion in the context of increased atrial workload 4 . EAT can contribute to the fibrotic 1 remodeling of the subepicardium by secreting adipo-fibrokines such as activin-A that freely 2 diffuse into the neighboring myocardium 10 . In addition, the adipose tissue depot commonly 3 seen in the subepicardium can be replaced by fibrosis through an immune process mediated by 4 CD8+ T lymphocytes 11 . Altogether these results suggest a balance between EAT expansion and 5 fibrosis of the subepicardium. 6
In the present study, we tested the hypothesis that the atrial epicardium can be a source 7 of fibroblasts contributing to the fibro-fatty infiltration of the subepicardium. We found that a 8 subset of aEPDCs are programmed towards fibroblast or adipocyte differentiation, and 9 contribute to fibro-fatty infiltration of the subepicardium in response to various stimuli. Our 10 results provide novel insight into the role played by the epicardium in the slow process of atrial 11 remodeling and the formation of AF substrate. Human tissue samples were obtained from patients that had undergone heart surgery. 5
Data and samples were obtained in accordance with French Law "loi Huriet-Sérusclat" and with 6 the approval of the Ethical Committee (Comité de protection du personnel Ile-de-France VI) of 7
Pitié-Salpétrière Hospital non-opposition to the research was obtained from each patient. 8
Personal Data treatment necessary to the research was declared to the National Commission for 9 Data Protection and Liberties (CNIL-France) under the Data Protection Act number 78-17. 10
Clinical parameters are indicated in Supplementary Table 1 . 11
Murine model. Both, eight-week-old male mice and rats were maintained under 12 h light/ 12 12 h dark cycle at constant temperature (21°C) with free access to food and water. Embryos were 13 staged as E11.5 or E16.5 days. WT1Cre ERT2+/and Rosa26 tdTomato+/+ on a C57BL/6J background 14 were purchased from The Jackson laboratories (L'arbresle, France). WT1Cre ERT2+/mice were 15 bred with Rosa26 tdT+/+ mice as described previously 4 . In order to label adult epicardium, 6 16
week-old WT1Cre ERT2+/-;Rosa26 tdT+/mice were administered tamoxifen (70mg/kg bw) for 5 17 consecutive days. Wistar rats were purchased from Janvier (200-220 g, CERJ, Laval, France). 18 WT1Cre ERT2+/-;Rosa26 tdT+/transgenic mice (n=10) and Wistar rats (n=50) were anesthetized 19 with Isoflurane 2 %. Mice and rats underwent thoracotomy and definitive occlusion of the left 20 anterior descending coronary artery was either left intact (sham) or occluded with a 5.0 nylon 21 monofilament suture at 1 mm from its origin to cause myocardial infarction (MI). 22
Clinical study of experimental models. Cardiomyopathy development in rat and mouse was 23 monitored under 1.5-2 % isoflurane anesthesia by transthoracic echocardiography as previously described 12 , using a Vivid 7 dimension cardiovascular ultrasound system equipped with a probe 1 of 9-14 MHz frequency (GE Healthcare, Vélizy, France). Bi-dimensional (B) and time-motion 2 (TM) mode views were recorded along the parasternal long axis from mitral and aortic valves 3 to apex and in a short axis at the level of the mid papillary muscles. Left atrial area (LAA) was 4 measured using B-mode. TM-mode was used for measurements of left atrial diameter and left 5 ventricle parameters such as diameter (Vd) and volume (Vd) at end diastole, diameter (Ds) and 6 volume (Vs) at end systole. The percentage of left ventricular fractional shortening (FS) in the 7 long-axis view was calculated as (Dd -Ds)/Dd x 100. The left ventricle ejection fraction 8 percentage (EF) was calculated as (Vd-Vs)/Vd x 100. All measurements were performed and 9 averaged over five consecutive cardiac cycles by one single blinded operator. Reproducibility 10 was assessed by triplicate measurements. 11
Atrial fibrillation episodes were induced by atrial burst pacing. Under anesthesia, a 4-12
French stimulation catheter (Saint Jude medical) was inserted into the esophagus down to the 13 level of the left atria. Left atrial was then stimulated for 3 seconds at 10 Hz and an 14 electrocardiogram (ECG) was recorded. AF duration was calculated as the time between the 15 end of stimulation and recovery of sinus rhythm. 16
Human tissue. Appendage samples of human atrial tissue were obtained for secretome studies 17 (n=10), fixed and embedded in paraffin (n=109) for histology and immunofluorescence analysis 18 or were used for the isolation of epicardial progenitor cells (n=15) as previously described 19
( Supplementary Table 1 
) 4 . 20
Histology. Mouse and rat hearts were removed, perfused through the aorta with PBS, fixed in 21 4 % paraformaldehyde (PFA) overnight. Mouse hearts were then dehydrated overnight in 22 sucrose and embedded in OCT and frozen as described previously 4 . Human atrial appendage 23 samples or rat hearts were fixed, dehydrated and paraffin embedded. Seven-µm-thick sections 7 atria samples were stained with Masson's trichrome according to manufacturer's instructions 1 (Sigma-aldrich). Bright field images were acquired with a Nikon DS-Ri1 camera coupled to 2 Eclipse-Ti Nikon microscope and Nis-Element software (Nikon France S.A.) and analyzed with 3 Image J software. 4
Histomorphometry. Seven-µm-thick sections of human or murine atrial samples were stained 5 with PicroSirius red according to manufacturer's instructions (Sigma-aldrich). Bright images 6 were acquired with a Nikon DS-Ri1 camera coupled to Eclipse-Ti Nikon microscope and Nis-7 Element software (Nikon France S.A.) and analyzed with Histolab software (Evry, France). 8
Collagen type I and III were visualized with polarization microscopy. The identification of 9 fibers was based on the birefringence of collagen that was modulated by the binding of 10 PicroSirius molecules. Polarization images were acquired with a Zeiss AxioObserver Z1 (Carl 11 Zeiss, Germany) microscope, using a 20x NA 0.8 oil immersion objective and a Zeiss HRc 12 camera. For image acquisition we used ZEN Blue software (Carl Zeiss, Germany). 13
Differentiation of aEPDCs. Human aEPDCs were culture in basal DMEM/M199 (1:1) and 14 were differentiated into adipocytes with ANP (10 pM) for 21 days as described previously 4 . To 15 induce human aEPDC-derived fibroblasts, progenitors were incubated in basal medium 16 supplemented with Ang-II (10 nM) or TGF- (10 nM) (Sigma-Aldrich) for 7 or 21 days. A 17 fibrogenic medium was used as a positive control, composed of DMEM/F12 (Invitrogen) 18 supplemented with L-glutamin (2 mM), FCS (10 %) (Sigma-Aldrich), b-FGF (10 ng/ml), TGF-19  (10 nM) and penicillin-streptomycin (1%) (ThermoFisher Scientific) [13] [14] [15] . All media were 20 changed twice per week. 21
Immunofluorescence assay. Adult EPDC-derived fibroblasts, human or murine atria tissue 22 sections were incubated overnight with antibodies against collagen-1 (ab34710), SMA 23 (ab7817), PDGFR (ab5460), DDR2 (ab126773), FSP-1 (ab27957), WT1 (ab96792), Pref1 (ab119930), fibronectin (ab2413), Perilipin (ab3526), AGTR1 (ab124505), NPRA (ab70848) 1 or Tcf21 (ab32981) purchased from Abcam and vimentin (#5741) or CD44 (#3570) purchased 2 from Ozyme. Then antibodies were revealed using Alexa-Fluor 488 or Alexa-Fluor 594 3 secondary antibodies (Thermo Fisher Scientific). Sections also were incubated with DAPI 4 solution (Sigma-Aldrich). Images were acquired with a Nikon DS-Ri1 camera coupled to an 5
Eclipse-Ti Nikon microscope and Nis-Element software (Nikon France S.A.) or Zeiss LSM800 6 (Carl Zeiss, Germany) and analyzed with Image J software. 7
Oil red O staining. Adult EPDC-derived cells were fixed with PFA (4 %) and stained with oil-8 red-O as described previously 4 . All images were acquired with a Nikon DS-Ri1 camera coupled 9
to an Eclipse-Ti Nikon microscope and Nis-Element software (Nikon France S.A.), and 10 analyzed with Image J software. 11
Flow Cytometry and cell sorting. Characterization of human aEPDCs was assessed by using 12 1.10 6 cells/mL. Cells were passaged using TrypLE (Applied Biosystems) and were washed with 13 PBS containing 5 % (vol/vol) FCS as described previously. 14 Human aEPDCs were incubated with specific membrane antibodies against PDGFR 15 (ab5460), DDR2 (ab126773), Pref1 (ab21682; Abcam), Perilipin (ab3526; Abcam), AGTR1 16 (ab124505) or NPRA (ab70848) purchased from Abcam, and their specific isotype controls for 17 30 min at room temperature. Cells then were incubated with Alexa-Fluor 650, washed, fixed 18 with 0.1 % PFA, and analyzed by flow cytometry using a MACSQuant analyzer (Miltenyi 19 Biotech, Paris, France), and FlowJo software (FlowJo LLC). Cells sorting was performed with 20 coupled antibodies against PDGFR-FITC or Pref1-APC. Cells were sorted by ASTRIOS 21 (Beckman Coulter, Villepinte, France) and were cultured in aEPDC culture medium. 22
Single cell RNA-sequencing. Adult EPDCs from sham or HF rats were isolated from atrial 23 epicardium explants and passaged once in culture. Epicardial cells and aEPDC in culture were dissociated with trypsin into a single cell suspension in the presence of 100 nM thiazovivin, 1 filtered through a 40 m mesh and 10 000 cells were processed with the SingleCell3 Reagent 2 Kit on the Chromium platform as described by the manufacturer (10X genomics). cDNA 3 libraries were sequenced with a Next-seq Illumina sequencer. A first analysis was performed 4 with cell Ranger and C-loop 10X genomics softwares. Clusters and subclusters were defined 5 using genes differentially expressed in cell clusters in comparison with all other cells with a 6 threshold of Log2 equal to at least 2. Then a secondary analysis was done using the computional 7 workflow ScshinyHub (https://github.com/baj12/scShinyHub), developed by B. Jagla at 8
Pasteur Institute, Paris. A total number of 16 400 genes were detected and an average of 9 3400 genes was expressed in all cells. Trajectory inference was performed using SCORPIUS 10 package within ScshinyHub. 11 RNA Extraction and Reverse Transcription and qPCR Assay. Total RNA was isolated from 12 1.10 4 aEPDCs-derived fibroblasts and qPCR was performed using a TaqMan Gene Expression 13
Assay as described previously 4 ( Supplementary Table 2 ). Expression relative to GAPDH was 14 calculated using the 2-(ΔΔCt) method. Gene expression levels were expressed in arbitrary units 15 (AU) and were normalized to control. 16
Western Blot Analysis. Human aEPDCs were cultured in six-well plates and were treated with 17 fibrogenic medium or Ang-II (10 nM) for 7 days. Cellular lysis was performed as described 18 previously 4 . Proteins (10 μg) were separated on 10 % (vol/vol) SDS-polyacrylamide gels 19 followed by electrophoretic transfer of protein to nitrocellulose membrane (Thermo Fisher 20 Scientific). Membranes were incubated overnight with antibodies against Smad2/3 (#8685 and 21 #3122) or p38-MAPK (#4511 and #9212) (Ozyme). Expression levels relative to GAPDH (# 22 2118; Ozyme) were expressed in arbitrary units and were normalized to control. Membranes 23 were revealed using streptavidin-HRP-conjugated secondary antibody solution (Thermo Fisher 24 Scientific). Membranes were exposed to an Image Quant LAS4000 camera (GE Healthcare) 1 and were analyzed with Image J software. 2
Statistics. Data obtained are expressed as means ± S.E.M. Differences were investigated using 3 un-paired 2-tailed Student's t-test or a one-way analysis of variance (ANOVA) with 4
Bonfferoni's post-hoc test, considered significant at P < 0.05. Statistical analysis was performed 5 with Prism GraphPad 6.0 (Software Inc.). 6
Before any statistical analyses of histomorphometry, log-transformation was applied to 7 reduce any skewness in the distribution of the epicardial adipose tissue and epicardial fibrosis 8 variables. Pearson correlation coefficients were computed between biological and 9 anthropometric variables while adjusting for age, gender and BMI when appropriate. 10
Association of biological parameters with clinical outcomes was assessed using logistic 11 regression adjusted for age and gender. The statistical threshold used for declaring statistical 12 association was fixed to 0.05. Analyses were performed using the R statistical computing 13 software. 14
15
Results 1
Evidence for epicardium activation and remodeling in human atria 2
In human right atrial tissue sections, the epicardium presented various histological aspects. 3
These included a thin cell monolayer separated from adjacent myocardium ( Fig. 1a , (i)) or 4 adipose tissue ( Fig. 1a, ( ii)) by a regularly arranged basal extracellular matrix (ECM) mainly 5 composed of collagen-1 ( Fig. 1a , (iii)). Alternatively, it constituted a thick layer (47.43 ± 17.7 6 mm²) in continuity with dense fibrosis (Fig. 1a, ( iii,iv)). Under polarized light, extracellular 7 matrix of the thin epicardium was mainly composed of regularly arranged yellow-red strong 8 birefringence collagen-1 ( Fig. 1b, ( ii)), whereas in thick and fibrotic epicardium, collagen-1 and 9 -3 (yellow-green birefringence) fibers were disorganized ( Fig. 1b, ( iii,iv)) 16 . A number of cells 10 co-expressing mesenchymal cell markers SMA (8.4 ± 0.9%) or PDGFR (10.3 ± 2.1 %) were 11 present in the thick and fibrotic epicardium ( Fig. 1c , Supplementary Table 3a ). 12
The percentage of fatty infiltrates correlated negatively with the epicardium thickness 13 (-0.52, P<0.01, n=109) suggesting a mutual exclusion of the two histological components. 14 Hence, the ratio of adipose tissue to epicardial fibrosis (EAT/epi Fibrosis) was used as a marker 15 of epicardial area remodeling. Looking deeply into these data revealed that EAT/epi Fibrosis 16 tended to differentially associate with clinical outcomes according to patient age. Indeed, in 17 patients over 70 years-old (which corresponds to the median age in our population), we 18 observed that the EAT/epi Fibrosis ratio significantly decreased in atrial sections from patients 19 with valve mitral diseases (0.33 vs 0.84, p < 0.05) and that there was a tendency to decrease in 20 patients with permanent AF (0.32 vs 0.86, p = 0.211) with no overlap between both groups 21 ( Supplementary Table 4 ). These histological observations suggest that low grade activation of 22 the epicardium can contribute to the remodeling of the atrial myocardium. 23 24
Recruitment of epicardial progenitors into the subepicardium of human atria
We previously reported the presence of cells expressing the marker of epicardial progenitors 1
Wilm's tumor (WT)-1 and of pre-adipocytes in the subepicardium of human atria 4 . Here, we 2 found that WT-1 positive cells expressing markers of myofibroblasts (SMA) or fibroblasts 3 (PDGFR) too were detected in the subepicardium of human atria ( Fig. 1d ) ( Supplementary  4   Table 3a) . 5
These data raised the question as to the presence of subset of cells derived from 6 epicardial progenitors and that could differentiate into distinct mesenchymal cell lines i.e 7 adipocyte or fibroblasts. This idea was further supported by the observation that atrial aEPDCs 8 showed distinct behavior in culture when treated with a myocardial secretome from human 9 atria. After 21 days in culture, one-third of the cells presented fibroblast phenotypes including 10 an elongated shape and expression of ECM proteins such as collagen-1 and fibronectin together 11 with fibroblast markers such as vimentin, SMA, PDGFR and DDR2. The remaining two-12 thirds showed an adipocyte phenotype, expressing perilipin and containing lipid droplets (Fig.  13 2a-c). 14 Next, aEPDCs were sorted based on the expression of Pref1 or PDGFR( Fig. 2d ) After 15 21 days of culture in the presence of a fibrogenic medium, only PDGFR + cells presented 16 fibroblast phenotypes with SMA labeling ( Fig. 2e,f) . In contrast, in the presence of an 17 adipogenic medium, only Pref1 + cells became round-shaped and contained oil red-O stained 18 lipid droplets and expressed perilipin typical of adipocytes ( Fig. 2e,f ). In addition, fibrogenic 19 gene expression was observed in PDGFR + cells when cultured in fibrogenic medium, whereas 20 Pref1 + cells cultured under adipogenic medium induced expression of adipocyte transcripts 21 ( Fig. 2g ). These results suggest that distinct populations of aEPDCs can differentiate into 22 fibroblast or adipocytes in response to various hormonal stimulations. 23 1
Following our previous finding of the presence of the adipogenic factor ANP in myocardial 2 secretome (MYO-S) 4 , we hypothesized that fibrogenic factors were also present in the 3 secretome. Several candidates were detected in MYO-S such as TGF- or Angiotensin (Ang)-4 II 4 . Interestingly, in vitro, aEPDCs acquired a fibroblast phenotype in the presence of Ang-II or 5 TGF-, as indicated by the up-regulation of PDGFR and DDR2 ( Fig. 3a , Supplementary Fig.  6 1a). In addition, at the transcript level, expression of the various ECM and fibroblast genes were 7 up-regulated (COL1A1, CTGF, TGFB, PDGFR and FSP1) whereas that of adipogenic 8 (CEBP/, PPAR, PERILIPIN-1) genes were down-regulated in Ang-II treated cells compared 9 with ANP treated cells (Fig. 3b,c, Supplementary Fig. 1b ). Moreover, Ang-II inhibited 10 perilipin-1 protein expression compared to ANP (Fig. 3d ) and a subset of aEPDCs remained 11
Pref-1 + (Fig. 3e) . Finally, the fibrogenic canonic Smad2/3 and p38-MAPK signaling pathways 12 were activated in this culture condition (Fig. 3f) 17, 18 . 13
Interestingly, both transcript levels and the plasma membrane expression of 14
Angiotensin-II receptor 1 (AGTR1) were induced by Ang-II in aEPDCs, whereas the ANP 15 receptor, NPRA, was undetectable ( Fig. 3d,e ). The opposite result was obtained in cells treated 16 with ANP i.e up-regulation of NPRA and down regulation of AGTR1 expression were observed 17 ( Fig. 3d,e ). Flow cytometry showed that Ang-II increased the fraction of cells expressing 18 PDGFR and the pre-adipocyte marker, Pref1, whereas cell expressing perilipin, i.e. mature 19 adipocytes, could not be detected (Fig. 3a, 3e) . These results indicate that distinct signaling 20 pathways regulate aEPDC differentiation. 21
22
Adult EPDC are recruited of at early stage of experimental atrial remodeling 23
To examine whether the epicardium is activated during the atrial remodeling, we studied a well-24 characterized model of atrial remodeling secondary to ischemic HF in rats 19 . Two months following the onset of the ischemic cardiopathy, all animals were in HF with dilated atria (Fig.  1 4a,b, and Supplementary Fig. 2a-c) . They showed a vulnerability to AF as indicated by a longer 2 duration of triggered episodes of AF compared to shams ( Supplementary Fig. 2d,e ). After 3 sacrifice, histological analysis revealed a hypertrophied and fibrotic myocardium in dilated atria 4 of HF rats compared to sham (epicardial fibrosis area in atria 70.3 ± 8.3 % vs 42.8.2 ± 7.9 %, 5 P < 0.001) (Fig. 4a,b ). In addition, collagen-1 and collagen-3 were also disorganized and 6 irregularly arranged (Fig. 4c) . 7
Interestingly, the epicardium was thick (epicardial fibrosis area in atria 78.95 ± 1.6 % 8 vs 56.61 ± 4%, p < 0.001) and a packed fibrosis composed of collagen and fibronectin depots 9 was observed in the subepicardium of dilated atria of HF rat (Fig. 4d ). Both fibroblasts 10 expressing PDGFR and myofibroblasts expressing SMA were detected in the subepicardial 11 fibrosis (Fig. 4d,e ). In addition, adipocytes were observed (epicardial adipocyte area in atria 12 37.72 ± 6.13 %, P < 0.05) (Fig. 4a ). Expansion of the epicardium was observed already one 13
week after MI (80.12 ± 8.6 % vs 55.25 ± 7.1 %, p < 0.01), and reached a plateau with 14 progression of the cardiomyopathy (Fig. 4a,b) . Some cells were double-positive for SMA and 15 WT1 or PDGFR and Tcf21, a transcription factor involved in fibroblast cell fate acquisition 20 16 ( Fig. 4e ,f, Supplementary Table 3b ). Interestingly, some WT1(+); Pref-1(+) cells were localized 17 in epicardial monolayer (Fig. 4e ,f, Supplementary Table 3b ). These results indicate that 18 epicardium expansion is an early event in the development of atrial cardiomyopathy and that 19 fibroblasts derived from activated epicardium could contribute to the remodeling of the atrial 20 subepicardium. 21
Evidence for epicardial progenitor origin of fibroblasts in the atrial subepicardium 23
In order to obtain direct evidence that epicardium could be a source of fibroblasts during atrial 24 remodeling, we reproduced the model of atrial cardiomyopathy secondary to ischemic HF in the WT1Cre ERT2+/-;ROSA26 tdT+/mice, allowing genetic lineage tracing of WT1-positive 1 epicardial progenitor cells in adult heart 2,4,21, 22 . As in rats, two months after surgical MI, mice 2 had developed HF with dilated and remodeled atria ( Supplementary Fig. 2f-h ). Furthermore, 3 the epicardium was thick and remodeled (epicardial fibrosis area in atria 78.13 ± 5.5 vs 53.46 4 ± 4.5, p < 0.001) with packed and dense fibrosis (Fig. 5a,b) . 5
As expected tdT + -WT1 + cells predominated in the epicardial layer in both sham and HF 6 mice (Fig. 5c ). In contrast, only in the latter group, tdT + cells were seen in the sup-epicardium 7 of the atria indicating epicardial activation and aEPDC migration (Fig. 5c ). Some of the WT1-8 positive cells of sup-epicardium expressed either SMA or PDGFR (Fig. 5c ). Atrial epicardial 9 progenitors in WT1Cre ERT2+/-;Rosa26 tdT+/mice also expressed the fibroblast marker Tcf21 (Fig.  10   5d ). More limited numbers of adult epicardium derived PDGFR + fibroblasts were found in the 11 subepicardium of the atria (Fig. 5e ). Of note, epicardial-derived myofibroblasts were observed 12 associated only with atrial epicardium but not with ventricular epicardium outside of the 13 infarcted area (Fig. 5e ). Interestingly, we observed heterogeneous expression of PDGFR and 14 Pref1 in embryonic and adult atrial epicardium, suggesting that epicardial cell heterogeneity 15 may underlie aEPDC composite ( Supplementary Fig. 3a ). In embryo at E11.5, both Pref-1(+) 16
and PDGFRa(+) cells were located in epicardium monolayer ( Supplementary Fig. 3a ). 17 Interestingly, after EMT process (E16.5) 23 , only Pref1(+) cells were observed in epicardium 18
whereas PDGFRa(+) were in sub-epicardium similar to sham adult atria ( Supplementary Fig.  19 3a). In addition, in embryos, epicardium contained Pref1(+) cells was co-expressed with NPRA 20 and PDGFRa(+) cells was co-expressed with AGTR1 ( Supplementary Fig. 3b,c) . These results 21 indicate that resident atria epicardial progenitor cells reactivate to differentiate into fibroblasts 22 or adipocyte during atrial remodeling. 23
Single cell RNA-sequencing analysis and the evidence for subset of aEPDC recruited 1 during atrial remodeling 2
Explants of rat atria from healthy (sham) or HF rat were cultured until epicardial cells migrated 3 outside the explants. Cells were then sub-cultured for one passage and used for single cell RNA-4 sequencing. 5
We used a non-linear dimensionality reduction method (t-stochastic neighbor 6 embedding t-SNE) to plot the data. In rat atria epicardium, ten clusters were defined in 7 differentially expressed genes in aEPDCs ( Fig. 6a , Supplementary Table 5 ). Two major 8 populations expressing WT1 + and PDGFR + , respectively, were clearly identifiable in both 9 healthy and HF samples (Fig. 6b ). Interestingly the WT1 + population expressed PDGFR and 10 ATGR1 (Fig. 6b) . Some cells at the border of the fibroblast cluster facing the epicardial WT1 + 11 cluster highly expressed both ATGR1 and PDGFR (Fig. 6b ). No significant difference in 12 expression of WT1, ATGR1, FSTL1 or NPRA is detected in epicardial cells from healthy or 13 diseased rat hearts ( Supplementary Fig. 4 ). 3D Tsne1 revealed a segregation of cells between 14 sham and HF samples (Fig. 6c ). 15
On the other hand, comparison by t-SNE of the aEPDC populations in both healthy and 16 diseased atria revealed major differences. A heatmap of five modules of differentially expressed 17 fibrosis-relevant genes (S100A4, COL1A1, COL3A1) plotted from healthy and remodeled rat 18 atria aEPDCs revealed major differences in the extent of fibrosis in each cell population 19 ( Supplementary Fig. 5 ). Violin plots of COL1A1 and -3A1, two markers of fibroblast ECM 20 confirmed fibrosis in HF aEPDCs ( Fig. 6e, Supplementary Fig. 5 ). 21
Next, we further investigated the fibrosis process in HF aEPDCs. Clustering of HF 22
EPDCs showed the heterogeneity of the cell population (Fig. 6a ). We first applied a linear 23 inference trajectory analysis to both sham and HF rat aEPDCs. This analysis revealed that cell 24 transcriptomic profiles segregated the two aEPDCs populations ( Supplementary Fig 6) . In order to track the fibro-fatty pathological process of diseased atria, we thus performed linear 1 trajectory inference on the HF rat aEPDCs (Fig. 7a,b ). This analysis revealed that few aEPDCs 2 at the starting point of the trajectory (cluster 10, mesothelial cells) still expressed mesothelial 3 markers such as MSLN. Then, aEPDCs transitioned from adipogenic (BMP4, LUM, UCP2) to 4 fibrotic (COL1A1, COL3A1, FN1) cell types (Fig. 7b,c, Supplementary Fig. 7 , Supplementary 5 Fig. 8 ). Adipogenic markers RACK1 has been reported as an inducer of PPAR-γ and C/EBP-6 β, and both RACK1 and BMP4 are involved in adipogenesis 24,25 as well as the elongation factor 7 EEF2 reported to be a mediator of adipogenesis 26 (module 1, Fig. 7c, Supplementary Fig 7, and  8 Supplementary Table 5 ). Modules 2 and 3, included cells undergoing the pathological process 9 of adipocyte to fibroblast transition that takes place under hypoxia in the likely presence of an 10 inflammatory phenomenon 27 (Fig. 7c, Supplementary Fig 7, and Supplementary Table 5 ). 11
Interestingly, CTGF, an inhibitor of adipogenesis 28 , was increased in module 2, an index of the 12 transition from adipose to fibrotic tissue. Finally, module 4 pointed to a feedback loop leading 13 to a de novo engagement of remaining epicardial mesothelial MSLN6+ cells through a process 14 of EMT (MFAP5) toward adipogenesis (COL6, CLMP) and inflammatory fibrosis (CCL2, 15 CCL7, IL33) ( Fig. 7c, Supplementary Fig 7, and Supplementary Table 5) . The accumulation of adipose and fibrosis tissue in the subepicardium has been recognized as 2 an important determinant of the formation of the substrate of AF and understanding how the 3 disease substrate develops is a key clinical issue. Herein, we found that following epicardial 4 EMT, adult EPDCs maintain an adipogenic potential in epicardial layer and that they can transit 5 to a fibrotic phenotype in response to various stimuli. 6
The origin of myofibroblasts and fibroblasts involved in extracellular matrix remodeling 7 of the myocardium is still debated 22, 29 . In adult mouse ventricles, challenged by transaortic 8 constriction or ischemia, most fibroblasts expand from developmentally-derived resident 9 fibroblasts 22, [29] [30] [31] . Furthermore, following acute myocardial ischemia, epicardium is also 10 activated and directly contributes to fibroblasts in the subepicardial area 2 . We provide evidence 11 that in the atria too, epicardial expansion results in de novo fibroblast generation. First, cells co-12 expressing markers of epicardial progenitors and fibroblasts can be detected in the 13 subepicardium of human and rat diseased atria, in agreement with a recent study 17 . Second, a 14 number of fibroblasts proximal to the remodeled adult atrial epicardium of WT1 CreERT2+/-15 ;ROSA26 tdT+/mice was labelled, pointing to their epicardial origin. Along these lines, it has 16 been reported that resident epicardial precursors from the right atrial appendages can 17 differentiate into fibroblasts, especially when obtained from AF patients 18 . 18
Distinct signaling pathways could operate as a switch to regulate the recruitment and 19 fate of these epicardial progenitor cells. Indeed, several growth factor signaling pathways have 20 been implicated in the induction of EMT, the recruitment of epicardial cells and their 21 differentiation into mesenchymal cell lines. For instance, PDGF acts on the transcription factor 22
Sox9 as a downstream target of PDGF stimulated EMT 23 . We reported previously that ANP is 23 a potent adipogenic factor for aEPDCs 4 . Here, we show that during embryonic development the expressing NPRA are localized in epicardium layer and AGTR1 + fibroblast precursors are 1 found in sub-epicardium layer. In adult, we found that Ang-II induced differentiation of 2 aEPDCs into fibroblasts by up-regulating its receptor, AGTR1, and by activating the canonical 3 Smad2/3 pathway 32,33 . Similarly, ANP up-regulated NPRA, and activated signaling resulting in 4 adipocyte differentiation of aEPDCs 4 . Our data further suggested a positive feedback of the 5 agonists on their signaling pathway by regulating expression of their own receptors to secure a 6 long-lasting response of cells to the agonists. Opposite effects of Ang-II and ANP on 7 fibrogenesis and adipogenesis, respectively, have been already reported. For instance, Ang-II 8 inhibited differentiation of human pre-adipocyte cells 34 . An anti-fibrogenic effect of ANP has 9 been described and attributed to the inhibition by the peptide of myofibroblast differentiation 10 and fibroblasts activation 35 . Finally, Ang-II down regulates NPR1 expression at the 11 transcription level 36 . These data suggest that from the embryo the epicardium progenitors could 12 be pre-defined into different fates and their re-activation is depend of local stimuli. 13
Using scRNA-seq, we were able to provide novel insight into aEPDC heterogeneity and 14 the relationships between aEPDC populations. Single cell RNA-seq analysis revealed six 15 clusters of atrial epicardial cells and aEPDCs, including two predominant epicardial WT1 + and 16 PDGFR + clusters, and identified adipogenic and fibrogenic potential of these cells. Another 17 major result provided by the scRNA-seq analysis of aEPDCs from diseased atria, is the process 18 of a transition of epicardial cells from adipose and then fibrotic tissue. Our scRNA-seq data 19 confirmed that a de novo EMT of remaining more resistant epicardial cells in the culture could 20 be triggered by hypoxia and inflammatory processes (module 4 , Fig 7c) , giving rise to adipose 21 tissue and further fibrosis as reported during obesity 37 . Indeed, linear trajectory inference 22 suggested a progression of the disease from transient accumulation of fat tissue towards fibrosis. 23
However, our data do not exclude that EPC undergoing EMT directly differentiate into 24 fibroblasts. 1 generation of fibroblasts could explain why thin epicardial layer co-exists with thick and 2 fibrotic epicardial area. This histological observation suggests that local mechanisms regulate 3 the activation the epicardium resulting in focal accumulation of adipocytes and fibroblasts. An 4 additional argument for local activation of the epicardium is that aEPDC-derived fibroblasts 5 are observed only in the atria but not in the ventricle of WT1 CreERT2+/-;Rosa26 tdT+/mice. 6
Moreover, the thick and fibrotic remodeled epicardium predominates in atria from aged patients 7 during clinical setting associated with atrial dilatation suggest that activation of the epicardium 8 is a low grade process that contributes with time to the progression of atrial remodeling and the 9 formation of AF substrate. Taken together, these histological and biological findings point to 10 the presence of a subpopulation of aEPDCs that are pre-engaged in adipogenic or fibrogenic 11 lineages, in the subepicardium and ready to be recruited in response to various stimuli, resulting, 12 with time, in different degrees of fibro fatty infiltrates. We found that subsets of cells derived from epicardial progenitors and confined into the 2 subepicardium regulate, the balance between AT expansion and fibrosis accumulation in the 3 atrial myocardium. Multiple factors coupled to signaling pathways can contribute to the 4 recruitment of these "post EMT EPC" from their subepicardial "niche". Our study provides a 5 biological basis for the slow and low noise remodeling of the atrial subepicardium which 6 progresses with time or during chronic cardiac diseases. It remains to determine when this 7 apparent aging phenomenon becomes pathological and can contribute to the substrate of AF. Myocytes. 20 
